Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Frontiers in Oncology|May 1, 2026
Primary urethral clear cell carcinoma: a rare case reportJiaxiang Yi, Weigang Ren, Weijie Song, et al.Vaccines|June 27, 2024
Advances in Nucleic Acid Universal Influenza VaccinesLiang Xu, Weigang Ren, Qin Wang, et al.Virus Genes|May 20, 2026
Roles of the M2 protein of influenza A virusWeigang Ren, Qin Wang, Yongxiang Yi, et al.Translational Andrology and Urology|July 12, 2026
The YTHDC1/HECW1/SMAD7 axis drives cisplatin resistance in bladder cancerWeigang Ren, Jiaxiang Yi, Mingqiang Zeng, et al.Drug Design, Development and Therapy|May 2, 2019
Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivoCuiling Zhang, Weigang Ren, Qingxin Liu, et al.Genetic Testing and Molecular Biomarkers|February 4, 2012
DNA repair gene XRCC3 T241M polymorphism and bladder cancer risk in a Chinese populationXuan Zhu, Zhaohui Zhong, Xuanzhi Zhang, et al.Vaccines|June 28, 2023
Real-World Safety of COVID-19 mRNA Vaccines: A Systematic Review and Meta-AnalysisWanqian Xu, Weigang Ren, Tongxin Wu, et al.The Tohoku Journal of Experimental Medicine|September 26, 2022
Exosomal miR-193b-3p Contributes to Cisplatin Sensitivity in Seminoma by Targeting ZBTB7AYong Wang, Jianjun Luo, Sheng Hu, et al.Experimental & Molecular Medicine|May 31, 2023
The YTHDC1/GLUT3/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progressionBin Yan, Xurui Li, Mou Peng, et al.Biochemical and Biophysical Research Communications|May 8, 2022
CBX7 represses the POU2F2 to inhibit the PD-L1 expression and regulate the immune response in bladder cancerWeigang Ren, Jiannan Ren, Naiwen Zhang, et al.Pageof 2